Variable | LSG (n = 72) n (%) | LTG (n = 31) n (%) | p value |
Type of tumor |
|
| >0.05 |
Squamous cell carcinoma | - | 1 (3.2) |
|
MALT lymphoma | - | 1 (3.2) |
|
Carcinoma in situ | 1 (1.4) | - |
|
GIST | 11 (15.3) | 1 (3.2) |
|
Adenocarcinoma | 60 (83.3) | 28 (90.3) |
|
Location of tumor |
|
|
|
Cardia | - | 11 (35.5) |
|
Body | 9 (12.5) | 15 (48.4) |
|
Lesser curvature | 14 (19.5) | 3 (9.6) |
|
Antrum | 49 (68.0) | 2 (6.5) |
|
Types of anastomosis |
|
| >0.05 |
Roux-en-Y | 56 (77.8) | 31 (100) |
|
Billroth II | 16 (22.2) | 0 |
|
Complications during hospitalization |
|
| <0.05 |
Pulmonary thromboembolism | 1 (1.4) | - |
|
Hematemesis/melena | 2 (2.8) | - |
|
Paralytic ileus | 1 (1.4) | 1 (3.2) |
|
Cardiac complications | 1 (1.4) | - |
|
Duodenal stump fistula | 2 (2.8) | - |
|
Abdominal sepsis without fistula | 1 (1.4) | - |
|
Hospital acquired pneumonia | 3 (4.2) | 6 (19.3) |
|
Gastro-jejunal anastomosis fistula | 2 (2.8) | - |
|
Esophago-jejunal anastomosis fistula | - | 4 (12.9) |
|
Postoperative survival |
|
| >0.05 |
Three-years | 38 (53.1) | 18 (59.3) |
|
Five-years | 34 (46.9) | 12 (40.7) |
|